绿康生化: directors' dealings · France · AMF SZSE:002868 FR FR · AMF Mcap 5.2Bn€
Explore the full management transaction log of 绿康生化, a publicly traded company based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €5.2bn. The latest transaction was reported on 9 February 2023 (Sale). Among the most active insiders: 冯真武. All data is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 516.6 M€
Gross profit 34.6 M€ 7% margin
Net income −139.3 M€ -27.0% margin
Balance sheet & cash
Market cap 5.24 Bn€
Total debt 359.8 M€
Free Cash Flow −154.9 M€
Last declaration on 9 February 2023
Declarations 12 total
Executives ● Sale7 SZSE
15,900 shares
SZSE:173000006267119420 · 9 Feb 2023
Executives ● Sale7 SZSE
570 shares
SZSE:173000005710493000 · 22 Jul 2022
Executives ● Sale7 SZSE
11,575 shares
SZSE:173000005697008160 · 19 Jul 2022
Executives ● Sale22 SZSE
308,354 shares
SZSE:173000005697008200 · 19 Jul 2022
Executives ● Sale7 SZSE
116,100 shares
SZSE:173000005697240670 · 15 Jul 2022
Executives ● Sale7 SZSE
8,200 shares
SZSE:173000005634904480 · 24 Jun 2022
Executives ● Sale22 SZSE
10,900 shares
SZSE:173000005614490270 · 20 Jun 2022
Executives ● Sale11 SZSE
11,575 shares
SZSE:173000005608357060 · 20 Jun 2022
Executives ● Sale7 SZSE
37,915 shares
SZSE:173000005588979620 · 14 Jun 2022
Executives ● Sale7 SZSE
10,000 shares
SZSE:173000005564565020 · 1 Jun 2022
Executives ● Sale11 SZSE
5,000 shares
SZSE:173000005507113730 · 5 May 2022
Executives ● Sale7 SZSE
4,000 shares
SZSE:173000005441235360 · 15 Apr 2022